Nandan Kulkarni

Stock Analyst at Bernstein

(1.41)
# 3,613
Out of 5,020 analysts
2
Total ratings
n/a
Success rate
-5.1%
Average return

Stocks Rated by Nandan Kulkarni

Mankind Pharma Limited
Jul 31, 2026
Reiterated: Sell
Price Target: ₹2,057
Current: ₹2,535
Upside: -18.86%